A carregar...
PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate
While gemfibrozil and fenofibrate are prescribed for anti-dyslipidemia treatment, a rational basis for the use of these drugs for treatment of dyslipidemia with concurrent metabolic syndrome has not been established. In this study, wild-type and Pparα-null mice were fed gemfibrozil- or fenofibrate-c...
Na minha lista:
| Publicado no: | Can J Physiol Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6334299/ https://ncbi.nlm.nih.gov/pubmed/27918198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1139/cjpp-2016-0140 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|